Very positive results for a proof of concept study IMO! Keen to see analysis by dose when full CSR is available and excited by potential for even greater benefits with a longer treatment duration (beyond 7 days as in this study) in subsequent larger phase 2 trial
- Forums
- ASX - By Stock
- IHL
- Ann: IHL-42X positive phase 2 clinical trial results
Ann: IHL-42X positive phase 2 clinical trial results, page-116
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online